Eptifibatide dosage forms and strengths: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Eptifibatide}} {{CMG}}; {{AE}} {{SS}} ==dosage forms and strengths== *Injection: 20 mg of INTEGRILIN in 10 mL (2 mg/mL), for intravenous bolus *Injection: 75 mg o...")
 
(Redirected page to Eptifibatide#How Supplied)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Eptifibatide#How Supplied]]
{{Eptifibatide}}
{{CMG}}; {{AE}} {{SS}}
 
==dosage forms and strengths==
*Injection: 20 mg of INTEGRILIN in 10 mL (2 mg/mL), for intravenous bolus
*Injection: 75 mg of INTEGRILIN in 100 mL (0.75 mg/mL), for intravenous infusion.
*Injection: 200 mg of INTEGRILIN in 100 mL (2 mg/mL), for intravenous infusion.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = INTEGRILIN (EPTIFIBATIDE) INJECTION, SOLUTION [MERCK SHARP & DOHME CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad82e30-50d8-450c-8a2a-b4b507ed1ce2 | publisher =  | date =  | accessdate = 5 February 2014 }}</ref>
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Antiplatelet drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 02:45, 22 July 2014